Trial intelligence / Profile preview

Paclitaxel and Estramustine in Relapsed Non-Hodgkin's Lymphoma

NCT00021372Phase 2Completed

Sponsor
Fox Chase Cancer Center
Start
Feb 1996
Primary completion
Sep 2006
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, estramustine in non-Hodgkin lymphoma (NHL), sponsored by Fox Chase Cancer Center. Started Feb 1996; status: completed.

02

Drugs

paclitaxelestramustine
03

Conditions

non-Hodgkin lymphoma (NHL)

Beyond the preview

Go deeper on NCT00021372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00021372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call